Completed PHASE2 INTERVENTIONAL 2-arm NCT02375243

Use of Dexmedetomidine in Children Undergoing Cardiac Surgery

Sponsor: Bambino Gesù Hospital and Research Institute

Updated 6 times since 2017 Last updated: Feb 11, 2017 Started: Feb 28, 2014 Primary completion: Dec 31, 2015 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02375243, this PHASE2 trial focuses on Deep Sedation and remains completed. Sponsored by Bambino Gesù Hospital and Research Institute, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bambino Gesù Hospital and Research Institute

Data source: Bambino Gesù Hospital and Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy